Friedman J A, Dwyer J T
New England Medical Center, Boston, MA, USA.
Nutr Rev. 1995 Jul;53(7):197-201. doi: 10.1111/j.1753-4887.1995.tb01551.x.
Hyperhomocysteinemia exists among patients both in end-stage renal disease and on dialysis and may represent an additional risk factor for increased cardiovascular disease. Supplementation with folic acid may reduce, but not correct, hyperhomocysteinemia. Evidence that lowering blood homocysteine will lessen cardiovascular risk is being sought.
高同型半胱氨酸血症存在于终末期肾病患者和透析患者中，可能是心血管疾病增加的另一个风险因素。补充叶酸可能会降低但不能纠正高同型半胱氨酸血症。目前正在寻找降低血液中同型半胱氨酸会降低心血管风险的证据。
